Septra DS - 61570-053-20 - (TRIMETHOPRIM and SULFAMETHOXAZOLE)

Alphabetical Index


Drug Information of Septra DS

Product NDC: 61570-053
Proprietary Name: Septra DS
Non Proprietary Name: TRIMETHOPRIM and SULFAMETHOXAZOLE
Active Ingredient(s): 800; 160    mg/1; mg/1 & nbsp;   TRIMETHOPRIM and SULFAMETHOXAZOLE
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Septra DS

Product NDC: 61570-053
Labeler Name: Monarch Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA017376
Marketing Category: NDA
Start Marketing Date: 19730730

Package Information of Septra DS

Package NDC: 61570-053-20
Package Description: 20 TABLET in 1 BOTTLE (61570-053-20)

NDC Information of Septra DS

NDC Code 61570-053-20
Proprietary Name Septra DS
Package Description 20 TABLET in 1 BOTTLE (61570-053-20)
Product NDC 61570-053
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name TRIMETHOPRIM and SULFAMETHOXAZOLE
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 19730730
Marketing Category Name NDA
Labeler Name Monarch Pharmaceuticals, Inc.
Substance Name SULFAMETHOXAZOLE; TRIMETHOPRIM
Strength Number 800; 160
Strength Unit mg/1; mg/1
Pharmaceutical Classes Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Sulfonamide Antimicrobial [EPC],Sulfonamides [Chemical/Ingredient]

Complete Information of Septra DS


General Information